Cholinesterase Inhibitors in the Clinical Management of Alzheimer's Disease: Importance of Early and Persistent Treatment

Author： Seltzer B  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.34, Iss.4, 2006-08, pp. : 339-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease: The Relationship Between Pharmacological Effects and Clinical Efficacy

By Wilkinson D.G.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 453-478

Adis International

Access to resources Recommend Favorite

Cholinergic Adverse Effects of Cholinesterase Inhibitors in Alzheimer's Disease: Epidemiology and Management

By Gauthier S.  

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 853-862

Adis International

Access to resources Recommend Favorite